This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

RAN-GABAPENTIN (2015-04-10)

Starting date:
April 10, 2015
Posting date:
April 14, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-52913

Recalled Products

RAN-Gabapentin

Reason

Possibility of contamination with trace amounts of the active ingredient Etodolac.

Depth of distribution

Retailers

Affected products

RAN-Gabapentin

DIN, NPN, DIN-HIM
DIN 02319055
Dosage form

Capsule

Strength

Gabapentin 100 mg

Lot or serial number

2582026

Companies
Recalling Firm
Ranbaxy Pharmaceuticals Canada Inc.
200-2680 Matheson Blvd. East
Mississauga
L4W 0A5
Ontario
CANADA
Marketing Authorization Holder
Ranbaxy Pharmaceuticals Canada Inc.
200-2680 Matheson Blvd. East
Mississauga
L4W 0A5
Ontario
CANADA


Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: